节点文献

健骨颗粒治疗绝经后骨质疏松症随机对照双盲双模拟多中心临床试验

Jiangu granules in treatment of postmenopausal osteoporosis:a randomized, double blind, double dummy, multi-center clinical trial

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 熊炎昊藤蔚然刘涛符诗聪顾品芳傅文彧李飞跃施荣庭奚小冰张凤华王毓兴唐旭升胡大佑李舸李中伟张昊高峰杜宁

【Author】 XIONG Yanhao 1,TENG Weiran 3 LIU Tao 1 FU Shicong 1 GU Pingfang 3 FU Wenyu 2 LI Feiyue 1 SHI Rongting 2 XI Xiaobing 1 hANG Fenghua 2 WANG Shuxing 1 TANG Xusheng 1 HU dayou 1 LI Ke 2 LI Zhongwei 2 ZHANG Hao 1 GAO Feng 1 DU Ning 1△ ( 1Department of Traumatology,Rui Jin Hospital,Shanghai Jiao Tong University School of Medicine 2Shanghai Institute of Traumatology and Orthopedics Shanghai 3Department of Traumatology, Xin Hua Hospital, Shanghai Jiao Tong University School of Medcine △corresponding author 200025 PRC)

【机构】 上海交通大学医学院附属瑞金医院伤科上海交通大学医学院附属新华医院伤科上海市伤骨科研究所上海交通大学医学院附属瑞金医院伤科 (上海200025)(上海

【摘要】 目的:考察健骨颗粒治疗妇女绝经后骨质疏松症的疗效,评价其有无开发成治疗绝经后骨质疏松症中药新药的可能性。方法:随机、双盲、双模拟、多种心研究方法。受试者均服用乐力钙250mgbid作为基础用药,再分别服用健骨颗粒5gBid、骨松宝颗粒5gBid、安慰剂颗粒5gBid,共6m。意向性数据集(ITT)样本144例,其中健骨颗粒组48例,骨松宝组48例,空白组48例。符合方案数据集(PP)样本108例,其中健骨颗粒组37例,骨松宝组36例,空白组35例。评价指标为脊柱、股骨颈及Wards区骨密度改善情况。结果:L2~L4骨密度治疗后骨松宝组及健骨颗粒组较治疗前都有增加(骨松宝组P=0.017,健骨颗粒组P=0.006),安慰剂治疗前后骨密度无明显变化;股骨颈及Wards区骨密度各组均无明显增加。三组间骨密度改善情况变化无统计学差异。结论:健骨颗粒和骨松宝对妇女绝经后骨质疏松的治疗作用相似,与乐力钙胶囊联用均能改善椎体骨密度。单独使用乐力钙胶囊能维持骨密度。

【Abstract】 Objective:To evaluate the efficacy of Jiangu granules in treatment of postmenopausal osteoporosis and the possibility of it to be exploited as a new clinical drug of traditional Chinese medicine (TCM). Methods:The study was designed as a randomized,double blind, double dummy and multi-center. The patients all received osteoform 250mg, bid as a fundamental drug.The patients separately received Jiangu granules, Gusongbao and placebo with the same dosage of 5g, bid. The whole treatment course was 6 months. The study enrolled 144 patients, according to intention to treat (ITT) principle, 48 patients in Jiangu group, 48 patients in Gusongbao group and 48 patients in placebo group. And finally 108 patients were available, according to per protocol set (PP) sample, 37 patients in Jiangu group, 36 patients in Gusongbao group and 35 patients in placebo group. The method of patient evaluation is the bone mineral density (BMD) including the spine, femoral neck and wards. Results:BMD increases significantly in the L2~L4 both in the Jiangu group and the Gusongbao group(Jiangu group:P=0.006,Gusongbao group:P=0.017). While the BMD in the femoral neck and wards have no significant improvement in all the three groups. There were no statistic differences in the changes of BMD among the three groups. Conclusion:Jiangu granules is an effective drug of TCM for osteoporosis and its efficacy is comparable to that of gusongbao. Both the two drugs can increase the BMD in the L2~L4 and maintain the BMD in the femoral neck and wards. Even the osteoform single can maintain the BMD in the three positions.

  • 【文献出处】 中国中医骨伤科杂志 ,Chinese Journal of Traditional Medical Traumatology & Orthopedics , 编辑部邮箱 ,2006年S2期
  • 【分类号】R259
  • 【被引频次】4
  • 【下载频次】219
节点文献中: